LH Laboratory Corp Of America Holdings
- Stocks
- Healthcare
- NYSE: LH
Price (delayed)
$250.69
Market cap
$20.78B
P/E Ratio
24.46
Dividend/share
$2.88
EPS
$10.25
Enterprise value
$26.71B
Relative Growth:
Rel. Growth:
67
Relative Strength:
Rel. Strength:
47
Relative Valuation:
Rel. Valuation:
79
Relative Profitability:
Rel. Profitability:
68
Laboratory Corporation of America Holdings, more commonly known as LabCorp, is an American S&P 500 company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks
Highlights
LH's net income has soared by 96% YoY and by 12% from the previous quarter
Laboratory Corp Of America Holdings's EPS has surged by 93% YoY and by 12% QoQ
The price to earnings (P/E) is 10% lower than the last 4 quarters average of 27.3 but 7% higher than the 5-year quarterly average of 22.8
Key stats
What are the main financial stats of LH
Market
Valuations
Earnings
Shares outstanding
82.9M
Market cap
$20.78B
Enterprise value
$26.71B
Price to earnings (P/E)
24.46
Price to book (P/B)
2.4
Price to sales (P/S)
1.51
PEG
0.26
EV/EBIT
20.06
EV/EBITDA
12.1
EV/Sales
1.94
Revenue
$13.77B
Gross profit
$3.92B
Operating income
$1.33B
Net income
$855.2M
EBIT
$1.33B
EBITDA
$2.21B
Free cash flow
$1.38B
Per share
Balance sheet
Liquidity
EPS
$10.25
EPS diluted
$10.19
Free cash flow per share
$16.62
Book value per share
$104.66
Revenue per share
$165.65
TBVPS
$96.36
Total assets
$18.26B
Total liabilities
$9.55B
Debt
$6.53B
Equity
$8.7B
Working capital
$1.45B
Debt to equity
0.75
Current ratio
1.55
Quick ratio
1.09
Net debt/EBITDA
2.69
Margins
Efficiency
Dividend
EBITDA margin
16%
Gross margin
28.4%
Net margin
6.2%
Operating margin
9.7%
Return on assets
4.7%
Return on equity
10.2%
Return on invested capital
11.8%
Return on capital employed
8.5%
Return on sales
9.7%
Dividend yield
1.15%
DPS
$2.88
Payout ratio
28.1%
LH stock price
How has the Laboratory Corp Of America Holdings stock price performed over time
Intraday
-0.65%
1 week
1.03%
1 month
-9.48%
1 year
9.42%
YTD
9.32%
QTD
-12.67%
Financial performance
How have Laboratory Corp Of America Holdings's revenue and profit performed over time
Revenue
$13.77B
Gross profit
$3.92B
Operating income
$1.33B
Net income
$855.2M
Gross margin
28.4%
Net margin
6.2%
LH's net income has soared by 96% YoY and by 12% from the previous quarter
The net margin has surged by 82% year-on-year and by 9% since the previous quarter
Laboratory Corp Of America Holdings's operating income has surged by 78% YoY and by 12% QoQ
The operating margin has soared by 64% YoY and by 10% from the previous quarter
Price vs fundamentals
How does LH's price correlate with its fundamentals
Growth
What is Laboratory Corp Of America Holdings's growth rate over time
Valuation
What is Laboratory Corp Of America Holdings stock price valuation
P/E
24.46
P/B
2.4
P/S
1.51
EV/EBIT
20.06
EV/EBITDA
12.1
EV/Sales
1.94
Laboratory Corp Of America Holdings's EPS has surged by 93% YoY and by 12% QoQ
The price to earnings (P/E) is 10% lower than the last 4 quarters average of 27.3 but 7% higher than the 5-year quarterly average of 22.8
The company's equity rose by 6% YoY and by 2.6% QoQ
The P/B is 4.3% higher than the 5-year quarterly average of 2.3 but 4% lower than the last 4 quarters average of 2.5
LH's price to sales (P/S) is 11% lower than its 5-year quarterly average of 1.7 and 6% lower than its last 4 quarters average of 1.6
LH's revenue is up by 8% year-on-year and by 2.1% since the previous quarter
Efficiency
How efficient is Laboratory Corp Of America Holdings business performance
LH's ROE has soared by 89% YoY and by 10% QoQ
LH's ROA has soared by 88% YoY and by 12% QoQ
Laboratory Corp Of America Holdings's return on sales has increased by 49% YoY and by 9% QoQ
The company's return on invested capital rose by 39% YoY and by 11% QoQ
Dividends
What is LH's dividend history
DPS
$2.88
Dividend yield
1.15%
Payout ratio
28.1%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Laboratory Corp Of America Holdings financials performed over time
LH's total assets is 91% greater than its total liabilities
The total liabilities has contracted by 8% YoY
Laboratory Corp Of America Holdings's current ratio has increased by 8% YoY and by 3.3% from the previous quarter
The debt is 25% smaller than the equity
LH's debt to equity is down by 20% year-on-year and by 2.6% since the previous quarter
The debt has declined by 15% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.